Hogge Gary S. Insider Trades

Insider Trading History

Track insider trading activity for Hogge Gary S.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Svp,clinical & Medical Affairs
Holding Value $484k 400,000 shares
Last Trade
Mar 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$584k 400,000 shares
$1.46
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Svp,clinical & Medical Affairs
Holding Value $47.3k 39,061 shares
Last Trade
Feb 11, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$17.6k 13,020 shares
$1.35
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Svp,clinical & Medical Affairs
Holding Value $15.8k 13,020 shares
Last Trade
Feb 11, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$17.6k 13,020 shares
$1.35
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Svp,clinical & Medical Affairs
Holding Value $9.33k 7,710 shares
Last Trade
Feb 11, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$7.17k 5,310 shares
$1.35
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Svp,clinical & Medical Affairs
Holding Value $545k 450,000 shares
Last Trade
Mar 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$630k 450,000 shares
$1.40
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Svp,clinical & Medical Affairs
Holding Value $63k 52,081 shares
Last Trade
Feb 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$78.1k 52,081 shares
$1.50
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Svp,clinical & Medical Affairs
Holding Value $45.6k 37,695 shares
Last Trade
Dec 29, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.5k 9,250 shares
$2.43
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Svp,clinical & Medical Affairs
Holding Value $302k 249,750 shares
Last Trade
Dec 29, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.5k 9,250 shares
$2.43
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Svp,clinical & Medical Affairs
Holding Value $34.4k 28,445 shares
Last Trade
Dec 29, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$92.4k 37,695 shares
$2.45
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Svp,clinical & Medical Affairs
Holding Value $313k 259,000 shares
Last Trade
Dec 28, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.23M 501,588 shares
$2.46
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Svp,clinical & Medical Affairs
Holding Value $34.4k 28,445 shares
Last Trade
Dec 28, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.23M 501,588 shares
$2.45
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Svp,clinical & Medical Affairs
Holding Value $641k 530,033 shares
Last Trade
Dec 28, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.23M 501,588 shares
$2.46
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Svp,clinical & Medical Affairs
Holding Value $508k 419,500 shares
Last Trade
Mar 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 419,500 shares
$2.43
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Svp,clinical & Medical Affairs
Holding Value $537k 444,000 shares
Last Trade
Mar 17, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$306k 444,000 shares
$0.69
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Svp,clinical & Medical Affairs
Holding Value $34.4k 28,445 shares
Last Trade
Mar 19, 2019 Sale
$565k 359,700 shares
$1.57
$1.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up